Andrew Guggenhime

Insider Reports History

Entity
Individual
Location
C/O Vaxcyte, Inc., 825 Industrial Road, Ste. 300, San Carlos, CA
Signature
Andrew Guggenhime, by /s/ Peter N. Efremenko, Attorney-In-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Andrew Guggenhime:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Vaxcyte, Inc. PRESIDENT AND CFO Common Stock 90.4K $9.96M $110.15 Sep 3, 2024 Direct
Caribou Biosciences, Inc. Director Option to purchase Common Stock 39.5K $106K $2.69 Feb 20, 2024 Direct
Vaxcyte, Inc. PRESIDENT AND CFO Stock Option (right to buy) 329K Aug 19, 2024 Direct
Metacrine, Inc. Director Stock Option (right to buy) 16.5K May 18, 2022 Direct

Insider Reports Filed by Andrew Guggenhime

Symbol Company Period Transactions Value $ Form Type Date Filed Role
PCVX Vaxcyte, Inc. Sep 3, 2024 1 -$698K 4 Sep 5, 2024 PRESIDENT AND CFO
PCVX Vaxcyte, Inc. Aug 19, 2024 4 -$586K 4 Aug 20, 2024 PRESIDENT AND CFO
PCVX Vaxcyte, Inc. Jul 18, 2024 6 -$607K 4 Jul 22, 2024 PRESIDENT AND CFO
PCVX Vaxcyte, Inc. Jun 18, 2024 4 -$533K 4 Jun 20, 2024 PRESIDENT AND CFO
PCVX Vaxcyte, Inc. May 20, 2024 4 -$557K 4 May 22, 2024 PRESIDENT AND CFO
PCVX Vaxcyte, Inc. Apr 18, 2024 4 -$447K 4 Apr 22, 2024 PRESIDENT AND CFO
PCVX Vaxcyte, Inc. Mar 18, 2024 4 -$509K 4 Mar 20, 2024 PRESIDENT AND CFO
PCVX Vaxcyte, Inc. Feb 29, 2024 3 -$272K 4 Mar 4, 2024 PRESIDENT AND CFO
CRBU Caribou Biosciences, Inc. Feb 20, 2024 1 $0 4 Feb 22, 2024 Director
PCVX Vaxcyte, Inc. Feb 20, 2024 5 -$553K 4 Feb 22, 2024 PRESIDENT AND CFO
PCVX Vaxcyte, Inc. Jan 18, 2024 6 -$443K 4 Jan 19, 2024 PRESIDENT AND CFO
PCVX Vaxcyte, Inc. Dec 18, 2023 4 -$439K 4 Dec 20, 2023 President and CFO
PCVX Vaxcyte, Inc. Dec 14, 2023 3 -$768K 4 Dec 18, 2023 President and CFO
PCVX Vaxcyte, Inc. Nov 20, 2023 4 -$366K 4 Nov 22, 2023 President and CFO
PCVX Vaxcyte, Inc. Oct 18, 2023 4 -$325K 4 Oct 20, 2023 President and CFO
PCVX Vaxcyte, Inc. Sep 5, 2023 1 -$182K 4 Sep 6, 2023 President and CFO
PCVX Vaxcyte, Inc. Mar 1, 2023 3 -$71.7K 4 Mar 3, 2023 President and CFO
CRBU Caribou Biosciences, Inc. Feb 21, 2023 1 $0 4 Feb 23, 2023 Director
PCVX Vaxcyte, Inc. Dec 30, 2022 3 $127K 4 Jan 4, 2023 President and CFO
PCVX Vaxcyte, Inc. Sep 19, 2022 4 -$64.3K 4 Sep 21, 2022 President and CFO
PCVX Vaxcyte, Inc. Sep 2, 2022 1 -$123K 4 Sep 7, 2022 President and CFO
PCVX Vaxcyte, Inc. Aug 25, 2022 9 -$815K 4 Aug 29, 2022 President and CFO
PCVX Vaxcyte, Inc. Aug 18, 2022 4 -$61.7K 4 Aug 22, 2022 President and CFO
PCVX Vaxcyte, Inc. Jul 18, 2022 4 -$59.5K 4 Jul 20, 2022 President and CFO
PCVX Vaxcyte, Inc. Jul 8, 2022 3 -$57.8K 4 Jul 12, 2022 President and CFO
MTCR Metacrine, Inc. May 18, 2022 1 $0 4 Sep 6, 2022 Director
PCVX Vaxcyte, Inc. May 18, 2022 4 -$59.2K 4 May 20, 2022 President and CFO
PCVX Vaxcyte, Inc. Apr 18, 2022 3 -$58K 4 Apr 20, 2022 President and CFO
PCVX Vaxcyte, Inc. Mar 18, 2022 3 -$64.4K 4 Mar 22, 2022 President and CFO
PCVX Vaxcyte, Inc. Mar 2, 2022 2 $0 4 Mar 4, 2022 President and CFO
PCVX Vaxcyte, Inc. Mar 1, 2022 3 -$116K 4 Mar 3, 2022 President and CFO
PCVX Vaxcyte, Inc. Dec 23, 2021 3 -$57.8K 4 Dec 28, 2021 President and CFO
CRBU Caribou Biosciences, Inc. Dec 20, 2021 1 $0 4 Dec 21, 2021 Director
PCVX Vaxcyte, Inc. Nov 18, 2021 4 -$59.4K 4 Nov 22, 2021 President and CFO
CRBU Caribou Biosciences, Inc. Jul 22, 2021 0 $0 3 Jul 22, 2021 Director
MTCR Metacrine, Inc. May 24, 2021 1 $0 4 May 25, 2021 Director